205 related articles for article (PubMed ID: 31227749)
1. BioTarget: A Computational Framework Identifying Cancer Type Specific Transcriptional Targets of Immune Response Pathways.
Hoang TH; Zhao Y; Lam Y; Piekos S; Han YC; Reilly C; Joshi P; Hong SH; Sung CO; Giardina C; Shin DG
Sci Rep; 2019 Jun; 9(1):9029. PubMed ID: 31227749
[TBL] [Abstract][Full Text] [Related]
2. Blimp-1 attenuates Th1 differentiation by repression of ifng, tbx21, and bcl6 gene expression.
Cimmino L; Martins GA; Liao J; Magnusdottir E; Grunig G; Perez RK; Calame KL
J Immunol; 2008 Aug; 181(4):2338-47. PubMed ID: 18684923
[TBL] [Abstract][Full Text] [Related]
3. Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function.
Sawant DV; Sehra S; Nguyen ET; Jadhav R; Englert K; Shinnakasu R; Hangoc G; Broxmeyer HE; Nakayama T; Perumal NB; Kaplan MH; Dent AL
J Immunol; 2012 Nov; 189(10):4759-69. PubMed ID: 23053511
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Notch signaling pathway reverses the Th1/Th2 imbalance in tuberculosis patients.
Li Q; Zhang H; Yu L; Wu C; Luo X; Sun H; Ding J
Int Immunopharmacol; 2018 Jan; 54():24-32. PubMed ID: 29100034
[TBL] [Abstract][Full Text] [Related]
5. Genetic reprogramming of primary human T cells reveals functional plasticity in Th cell differentiation.
Sundrud MS; Grill SM; Ni D; Nagata K; Alkan SS; Subramaniam A; Unutmaz D
J Immunol; 2003 Oct; 171(7):3542-9. PubMed ID: 14500650
[TBL] [Abstract][Full Text] [Related]
6. GATA3, HDAC6, and BCL6 Regulate FOXP3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg.
Xu K; Yang WY; Nanayakkara GK; Shao Y; Yang F; Hu W; Choi ET; Wang H; Yang X
Front Immunol; 2018; 9():45. PubMed ID: 29434588
[TBL] [Abstract][Full Text] [Related]
7. Enforced expression of GATA-3 in transgenic mice inhibits Th1 differentiation and induces the formation of a T1/ST2-expressing Th2-committed T cell compartment in vivo.
Nawijn MC; Dingjan GM; Ferreira R; Lambrecht BN; Karis A; Grosveld F; Savelkoul H; Hendriks RW
J Immunol; 2001 Jul; 167(2):724-32. PubMed ID: 11441076
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Th2 differentiation and GATA-3 expression by BCL-6.
Kusam S; Toney LM; Sato H; Dent AL
J Immunol; 2003 Mar; 170(5):2435-41. PubMed ID: 12594267
[TBL] [Abstract][Full Text] [Related]
9. Cell fate decision: T-helper 1 and 2 subsets in immune responses.
Dong C; Flavell RA
Arthritis Res; 2000; 2(3):179-188. PubMed ID: 11094427
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of CCL22 and mutated NOTCH1 in tongue and mouth floor squamous cell carcinoma results in decreased Th2 cell recruitment and expression, predicting poor clinical outcome.
Li X; Liu Z; Zhou W; Liu X; Cao W
BMC Cancer; 2021 Aug; 21(1):922. PubMed ID: 34391381
[TBL] [Abstract][Full Text] [Related]
11. The Runx3 transcription factor augments Th1 and down-modulates Th2 phenotypes by interacting with and attenuating GATA3.
Kohu K; Ohmori H; Wong WF; Onda D; Wakoh T; Kon S; Yamashita M; Nakayama T; Kubo M; Satake M
J Immunol; 2009 Dec; 183(12):7817-24. PubMed ID: 19933870
[TBL] [Abstract][Full Text] [Related]
12. The mutations of Th1 cell-specific T-box transcription factor may be associated with a predominant Th2 phenotype in gastric cancers.
Yang P; Qiu G; Wang S; Su Z; Chen J; Wang S; Kong F; Lu L; Ezaki T; Xu H
Int J Immunogenet; 2010 Apr; 37(2):111-5. PubMed ID: 20193034
[TBL] [Abstract][Full Text] [Related]
13. Identification of genes involved in the initiation of human Th1 or Th2 cell commitment.
Lund R; Ahlfors H; Kainonen E; Lahesmaa AM; Dixon C; Lahesmaa R
Eur J Immunol; 2005 Nov; 35(11):3307-19. PubMed ID: 16220538
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer.
Pichler R; Gruenbacher G; Culig Z; Brunner A; Fuchs D; Fritz J; Gander H; Rahm A; Thurnher M
Cancer Immunol Immunother; 2017 Apr; 66(4):427-440. PubMed ID: 28005163
[TBL] [Abstract][Full Text] [Related]
15. Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence.
Babu S; Blauvelt CP; Kumaraswami V; Nutman TB
J Immunol; 2006 Mar; 176(5):3248-56. PubMed ID: 16493086
[TBL] [Abstract][Full Text] [Related]
16. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch.
Amsen D; Antov A; Jankovic D; Sher A; Radtke F; Souabni A; Busslinger M; McCright B; Gridley T; Flavell RA
Immunity; 2007 Jul; 27(1):89-99. PubMed ID: 17658279
[TBL] [Abstract][Full Text] [Related]
17. Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions.
Hegazy AN; Peine M; Helmstetter C; Panse I; Fröhlich A; Bergthaler A; Flatz L; Pinschewer DD; Radbruch A; Löhning M
Immunity; 2010 Jan; 32(1):116-28. PubMed ID: 20079668
[TBL] [Abstract][Full Text] [Related]
18. Th1/Th2 cell's function in immune system.
Zhang Y; Zhang Y; Gu W; He L; Sun B
Adv Exp Med Biol; 2014; 841():45-65. PubMed ID: 25261204
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors.
Iwata M; Eshima Y; Kagechika H
Int Immunol; 2003 Aug; 15(8):1017-25. PubMed ID: 12882839
[TBL] [Abstract][Full Text] [Related]
20. The E3 Ubiquitin Ligase Asb2α in T Helper 2 Cells Negatively Regulates Antitumor Immunity in Colorectal Cancer.
Spinner CA; Lamsoul I; Métais A; Febrissy C; Moog-Lutz C; Lutz PG
Cancer Immunol Res; 2019 Aug; 7(8):1332-1344. PubMed ID: 31175139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
